Annovis Bio Statistics
Total Valuation
Annovis Bio has a market cap or net worth of $80.40 million. The enterprise value is $60.87 million.
| Market Cap | 80.40M |
| Enterprise Value | 60.87M |
Important Dates
The last earnings date was Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Annovis Bio has 42.54 million shares outstanding. The number of shares has increased by 67.97% in one year.
| Current Share Class | 42.54M |
| Shares Outstanding | 42.54M |
| Shares Change (YoY) | +67.97% |
| Shares Change (QoQ) | +29.94% |
| Owned by Insiders (%) | 11.48% |
| Owned by Institutions (%) | 13.53% |
| Float | 37.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.05 |
| P/TBV Ratio | 4.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.80
| Current Ratio | 5.80 |
| Quick Ratio | 5.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -220.61% and return on invested capital (ROIC) is -141.90%.
| Return on Equity (ROE) | -220.61% |
| Return on Assets (ROA) | -106.03% |
| Return on Invested Capital (ROIC) | -141.90% |
| Return on Capital Employed (ROCE) | -170.21% |
| Weighted Average Cost of Capital (WACC) | 10.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.12M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.67% in the last 52 weeks. The beta is 1.19, so Annovis Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -41.67% |
| 50-Day Moving Average | 2.02 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 44.22 |
| Average Volume (20 Days) | 1,286,477 |
Short Selling Information
The latest short interest is 4.67 million, so 10.99% of the outstanding shares have been sold short.
| Short Interest | 4.67M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 10.99% |
| Short % of Float | 12.41% |
| Short Ratio (days to cover) | 4.83 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.70M |
| Pretax Income | -28.85M |
| Net Income | -28.85M |
| EBITDA | n/a |
| EBIT | -29.70M |
| Earnings Per Share (EPS) | -$1.40 |
Balance Sheet
The company has $19.53 million in cash and n/a in debt, with a net cash position of $19.53 million or $0.46 per share.
| Cash & Cash Equivalents | 19.53M |
| Total Debt | n/a |
| Net Cash | 19.53M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | 16.85M |
| Book Value Per Share | 0.62 |
| Working Capital | 17.45M |
Cash Flow
| Operating Cash Flow | -25.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Annovis Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.97% |
| Shareholder Yield | -67.97% |
| Earnings Yield | -35.89% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Annovis Bio is $12.50, which is 561.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.50 |
| Price Target Difference | 561.38% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |